Breaking News

Toxikon Adds Cancer Assay

Toxikon has added the Comet Assay IV Analysis System developed by Perceptive Instruments to its genetic and molecular toxicology study offerings.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Toxikon has added the Comet Assay IV Analysis System developed by Perceptive Instruments to its genetic and molecular toxicology study offerings. This technology is used to accelerate the development of cancer-fighting drugs or for environmental monitoring, genetic toxicology platforms.

Toxikon also provides a range of services from bioanalysis to chronic studies to FISH, blue and green screen assays, as well as genetic toxicology studies for premarket approval and IND submission.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters